The Australian Commission on Quality and Safety in Health Care (ACSQHC) has released a draft Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard for consultation. The Standard describes the key components of care that people of all ages living with cognitive disability or impairment can expect to receive in all healthcare settings to reduce the inappropriate use of psychotropic medicines.
Currently more than 61% of Australian aged care residents take one or more psychotropic medicines and they are frequently prescribed for people with intellectual disability.
The Commission is seeking feedback from consumers, clinicians, health services and anyone with an interest in cognitive disability, cognitive impairment, aged care or disability services.
Share your feedback on the draft Standard and supporting resources using the online survey.
The consultation will close on Monday 8 May.